RxDoctor Payments Data

Kylie Hays, PA

Physician Assistant · Atlanta, GANPI 1134741044

Payments from drug & device makers

$5,775in general payments, 2019–2025

Across 406 payments — averaging $14.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Mayne Pharma Commercial LLC$1K
  • Novo Nordisk$836
  • AbbVie$778
  • Lilly USA, LLC$741
  • E.r. Squibb & Sons, L.L.C.$348
  • Amgen$279
  • plus $1K from 31 others

What the payments were for

  • Food & beverage$5,69599%
  • Education$801%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,775 in reported general payments places this provider in the 90th percentile of 3,581 physician assistant providers in Georgia.

See all physician assistant providers in Georgia

Medicare billing

Part B allowed, 2024
$38,102
Medicare patients
217
Services billed
1,066

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin12$16,605
Ciclopirox15$820
Gabapentin17$808
Clobetasol Propionate12$647
Fluorouracil11$579
Atorvastatin Calcium52$456
Triamcinolone Acetonide49$363
Ezetimibe12$351
Lisinopril46$327
Losartan Potassium36$326
Levothyroxine Sodium38$302
Tamsulosin Hcl13$259
Fluoxetine Hcl13$224
Omeprazole19$194
ValacyclovirValacyclovir Hcl12$191

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$16$16,60512 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$17$30238 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,581 physician assistant providers in Georgia.

Other physician assistant in Atlanta

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →